• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素及其代谢产物对离体灌注大鼠肾脏的影响。

Effects of cyclosporine and its metabolites in the isolated perfused rat kidney.

作者信息

Roby K A, Shaw L M

机构信息

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia.

出版信息

J Am Soc Nephrol. 1993 Aug;4(2):168-77. doi: 10.1681/ASN.V42168.

DOI:10.1681/ASN.V42168
PMID:8400080
Abstract

The isolated perfused rat kidney (IPK) was used to study the acute effects of cyclosporin A (CsA) and its metabolites (M1, M17, M18, M21 and M-COOH). GFR, renal vascular resistance, and sodium, potassium and water reabsorption were measured before and after the addition of CsA/metabolites/vehicles. There was no difference in CsA effect (mild decrease in GFR and increase in renal vascular resistance with the inclusion of plasma (10 mL) or whole blood (20 mL) in the albumin perfusate (120 mL). Intralipid was used as the vehicle for CsA and the metabolites because methanol, ethanol, and Cremophor had significant effects on GFR. Intralipid enhanced the effect of CsA 25-fold, giving CsA dose responses comparable to those of human kidneys. This enhanced effect with intralipid was due to vasoconstriction, not vascular obstruction, and was apparently specific to CsA (no enhancement of norepinephrine with Intralipid). The primary metabolites (M1, M17, and M21) caused decreases in GFR comparable to or slightly less than those caused by CsA. The secondary metabolites (M18 and M-COOH) caused more modest declines in GFR. Cyclosporine metabolite levels in patient blood often greatly exceed levels of the parent drug; these studies suggest that the metabolites may contribute significantly to CsA nephrotoxicity in patients.

摘要

采用离体灌注大鼠肾脏(IPK)研究环孢素A(CsA)及其代谢产物(M1、M17、M18、M21和M-COOH)的急性效应。在添加CsA/代谢产物/赋形剂前后,测量肾小球滤过率(GFR)、肾血管阻力以及钠、钾和水的重吸收。在白蛋白灌注液(120 mL)中加入血浆(10 mL)或全血(20 mL)时,CsA的效应无差异(GFR轻度降低,肾血管阻力增加)。由于甲醇、乙醇和聚氧乙烯蓖麻油对GFR有显著影响,因此使用脂质乳剂作为CsA及其代谢产物的赋形剂。脂质乳剂使CsA的效应增强了25倍,使CsA的剂量反应与人肾相当。脂质乳剂的这种增强效应是由于血管收缩而非血管阻塞,且显然对CsA具有特异性(脂质乳剂不会增强去甲肾上腺素的作用)。主要代谢产物(M1、M17和M21)导致GFR降低的程度与CsA相当或略低于CsA。次要代谢产物(M18和M-COOH)导致GFR下降幅度较小。患者血液中环孢素代谢产物水平常常大大超过母体药物水平;这些研究表明,代谢产物可能在很大程度上导致患者出现CsA肾毒性。

相似文献

1
Effects of cyclosporine and its metabolites in the isolated perfused rat kidney.环孢素及其代谢产物对离体灌注大鼠肾脏的影响。
J Am Soc Nephrol. 1993 Aug;4(2):168-77. doi: 10.1681/ASN.V42168.
2
Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL.
Transplantation. 1987 Aug;44(2):195-201. doi: 10.1097/00007890-198708000-00005.
3
The dose-dependent inhibition of rat renal translation elongation seen after in vivo cyclosporin A is not caused by cyclosporin metabolites.体内给予环孢素A后所观察到的对大鼠肾脏翻译延伸的剂量依赖性抑制并非由环孢素代谢产物所致。
Toxicology. 1995 Jun 26;100(1-3):17-25. doi: 10.1016/0300-483x(95)03053-i.
4
Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Nephrol Dial Transplant. 1996 Mar;11(3):507-13.
5
Effects of cyclosporine on the isolated perfused rat kidney.环孢素对离体灌注大鼠肾脏的影响。
Transplantation. 1987 Jun;43(6):795-9.
6
Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506.环孢素A代谢产物的抗过敏活性及其与母体化合物和FK 506的相互作用。
Int J Immunopharmacol. 1996 Apr;18(4):263-70. doi: 10.1016/0192-0561(96)84506-1.
7
Protective effect of verapamil in cyclosporin-incubated human and murine isolated glomeruli.维拉帕米对环孢素处理的人及小鼠离体肾小球的保护作用。
Ren Fail. 1994 Nov;16(6):665-72. doi: 10.3109/08860229409044895.
8
Prevention of acute cyclosporin nephrotoxicity by verapamil and atrial natriuretic factor in the rat.维拉帕米和心房利钠因子对大鼠急性环孢素肾毒性的预防作用
Nephrol Dial Transplant. 1994;9(8):1143-8. doi: 10.1093/ndt/9.8.1143.
9
Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.环孢素A在人肝、肾和肠切片中的代谢。与大鼠、犬切片及人细胞系的比较。
Drug Metab Dispos. 1992 Nov-Dec;20(6):802-9.
10
Mechanisms of ciclosporin A-induced vasoconstriction in the isolated perfused rat kidney.环孢素A诱导离体灌注大鼠肾脏血管收缩的机制
Nephron. 1992;60(4):477-81. doi: 10.1159/000186812.

引用本文的文献

1
Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin.伏环孢素的上市后安全性监测:一项利用FAERS数据库对伏环孢素安全性进行的观察性药物警戒研究。
Front Pharmacol. 2025 May 19;16:1506760. doi: 10.3389/fphar.2025.1506760. eCollection 2025.
2
Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.载环孢素 A 的聚乙二醇化壳聚糖修饰的基于脂质的纳米粒的制备及其体外和体内特性研究。
Int J Nanomedicine. 2013;8:601-10. doi: 10.2147/IJN.S39685. Epub 2013 Feb 5.
3
The genetics of kidney transplantation.
肾脏移植的遗传学。
Hum Genet. 2012 Mar;131(3):317-23. doi: 10.1007/s00439-011-1092-8. Epub 2011 Sep 16.